We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low Radiation Doses in Nature May Pose Risk

By Biotechdaily staff writers
Posted on 20 May 2002
A study has found that radiation can trigger widespread mutations in living cells at much lower doses than previously thought possible. More...
Conducted by researchers at Columbia University College of Physicians and Surgeons (New York, NY, USA), the study was published in the December 4, 2001, issue of the Proceedings of the National Academy of Sciences.

The study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic effect as a dose that strikes every cell. The added damage occurs because of what is called the "bystander effect,” in which injured cells send aberrant signals to neighboring cells. This effect occurs with alpha particles, which come from such sources as nuclear explosions, plutonium, and radon, a naturally occurring gas that seeps into many homes.

The risks of exposure to lower radiation levels are poorly understood and have been the subject of controversy for decades, say the researchers. In the study, they found that when they beamed alpha particles at only one in 10 cells, the results were almost the same as if they had beamed them at all cells. Nearly all the cells showed mutations in their DNA. However, the researchers found they could prevent widespread damage by blocking the signaling network that exists between cells. By using chemicals that obstruct key cell-to-cell pathways, the researchers could restrict the damage to the 10% of cells that had directly received alpha particles. This suggests that signaling networks are responsible for spreading the damage, but little is known about the signaling mechanism at this time.

Previously, public health officials have assumed the risk of radiation is proportional to the dose. Lower doses carry lower risk. The new findings suggest such a linear relationship might not be operating. Instead, the study suggests that at low doses, the risk rises steeply in proportion to the dose, while at higher doses, the risk rises more gently in relation to the dose.

According to Dr. Howard L. Liber, associate professor of radiobiology at Harvard School of Public Health, the study is "another piece of hard evidence to suggest we may need to reassess acceptable radiation levels.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.